Bone Rx Boosted Breast Cancer Survival
Nearly all postmenopausal women with early-stage HR+ breast cancer are treated with aromatase inhibitors. But these drugs can significantly compromise bone health and up the risk of fractures.
Breast Cancer Rx Might Prevent Early Menopause
It’s good news for young women who have had breast cancer treatment and still want a baby. A medication called goserelin may help prevent the ovarian failure often caused by chemotherapy.
Health Screenings Every Woman Should Know About
Staying healthy requires being proactive about your health by scheduling and attending necessary health screenings. There are some screenings in particular that every woman should know about.
Breast Cancer Treatment Had Lingering Health Effects
Women with breast cancer often receive radiation treatments and chemotherapy to fight their disease. In some women, those treatments might bring long-term health effects that aren’t so desirable.
Breast Cancer Survivors Battling Brittle Bones
Breast cancer survivors can have ongoing health challenges after they’ve beaten "The Big C." Many are on medications that block estrogen, the hormone that drives most breast cancers. These medicines also increase the risk of osteoporosis (brittle bones) and increase the risk of fractures.
Risks of a Life-Saving Surgery for Women
Women at risk of ovarian cancer are sometimes encouraged to get their ovaries removed. While ovary removal surgery can save a woman's life, it also may raise the risk of other health problems.
FDA Approves Prolia for osteoporosis
On September 16, 2011, the U.S. Food and Drug Administration granted approval for denosumab ( Prolia , Amgen Inc.) as a treatment to increase bone mass in patients at high risk for fracture receiving androgen deprivation therapy (ADT) for nonmetastatic prostate cancer or adjuvant aromatase inhibitor (AI) therapy for breast cancer. In men with nonmetastatic prostate cancer, denosumab also reduced the incidence of vertebral fracture.
New Findings on Hormone Replacement Therapy
You may remember some years ago when a large women's study was stopped because one of the therapies being tested was shown to actually increase the risk of breast cancer, heart attacks and strokes.